These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30348200)

  • 21. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
    Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
    Bussard KM; Venzon DJ; Mastro AM
    J Cell Biochem; 2010 Dec; 111(5):1138-48. PubMed ID: 20683902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
    Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
    PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
    Shi C; Qi J; Huang P; Jiang M; Zhou Q; Zhou H; Kang H; Qian N; Yang Q; Guo L; Deng L
    Bone; 2014 Nov; 68():67-75. PubMed ID: 25138550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
    Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
    J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
    Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
    Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
    Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
    Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of miR-125b in Osteoblasts Improves Age-Related Changes in Bone Mass and Quality through Suppression of Osteoclast Formation.
    Ito S; Minamizaki T; Kohno S; Sotomaru Y; Kitaura Y; Ohba S; Sugiyama T; Aubin JE; Tanimoto K; Yoshiko Y
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
    Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
    Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1.
    Kim KM; Park SJ; Jung SH; Kim EJ; Jogeswar G; Ajita J; Rhee Y; Kim CH; Lim SK
    J Bone Miner Res; 2012 Aug; 27(8):1669-79. PubMed ID: 22431396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche.
    Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F
    J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway.
    Li X; Zheng Y; Zheng Y; Huang Y; Zhang Y; Jia L; Li W
    Stem Cell Res Ther; 2018 Aug; 9(1):232. PubMed ID: 30170617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
    Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
    Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-16-2* Interferes with WNT5A to Regulate Osteogenesis of Mesenchymal Stem Cells.
    Duan L; Zhao H; Xiong Y; Tang X; Yang Y; Hu Z; Li C; Chen S; Yu X
    Cell Physiol Biochem; 2018; 51(3):1087-1102. PubMed ID: 30476907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-125b Regulates the Osteogenic Differentiation of Human Mesenchymal Stem Cells by Targeting BMPR1b.
    Wang H; Xie Z; Hou T; Li Z; Huang K; Gong J; Zhou W; Tang K; Xu J; Dong S
    Cell Physiol Biochem; 2017; 41(2):530-542. PubMed ID: 28214897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expression.
    Tang X; Lin J; Wang G; Lu J
    PLoS One; 2017; 12(6):e0179860. PubMed ID: 28628652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer cells interact with osteoblasts to support osteoclast formation.
    Thomas RJ; Guise TA; Yin JJ; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
    Endocrinology; 1999 Oct; 140(10):4451-8. PubMed ID: 10499498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
    Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
    Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.